Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-amino-4-(2,4-dichlorophenyl)-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide is a synthetic small molecule belonging to the phenylpyrimidines and thienopyrimidines chemical classes. It has been primarily studied as an experimental compound and is referenced in several chemical and drug databases (DrugBank DB08789; ChEMBL563168). The compound’s structure features a thienopyrimidine core substituted with dichlorophenyl and ethylcarboxamide groups. While it has been investigated for potential therapeutic applications—possibly as an inhibitor of heat shock protein HSP90-beta—there are no approved indications or detailed clinical development data available. Its mechanism of action remains uncharacterized in public sources[1][3][4][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-amino-4-(2,4-dichlorophenyl)-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide.